Ru-Huei Fu相关文献与解析，生知库 | 链接生命科学的每一步

Chie-Hong Wang, Guan-Cyun Lin, Ru-Huei Fu, Yu-Chuen Huang, Shih-Yin Chen, Shinn-Zong Lin, Horng-Jyh Harn, Woei-Cherng Shyu, Yi-Fang Huang, Long-Bin Jeng, Shih-Ping Liu

发育与干细胞

神经

帕金森

干细胞

发表日期：2024

文献求助收藏

Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson's Disease

Chiisanoside 通过下调 MiR-181a 介导 Parkin/ZNF746/PGC-1α 轴，从而改善 6-OHDA 引起的神经毒性模型中的线粒体生物合成（体外和体内）：预防帕金森病的建议

期刊:Antioxidants

影响因子:

doi:10.3390/antiox12091782

Yu-Ling Hsu, Hui-Jye Chen, Jia-Xin Gao, Ming-Yang Yang, Ru-Huei Fu

Glycine-Alanine Dipeptide Repeat Protein from C9-ALS Interacts with Sulfide Quinone Oxidoreductase (SQOR) to Induce the Activity of the NLRP3 Inflammasome in HMC3 Microglia: Irisflorentin Reverses This Interaction

C9-ALS 中的甘氨酸-丙氨酸二肽重复蛋白与硫化物醌氧化还原酶 (SQOR) 相互作用，诱导 HMC3 小胶质细胞中 NLRP3 炎症小体的活性：Irisflorentin 可逆转这种相互作用

期刊:Antioxidants

影响因子:

doi:10.3390/antiox12101896

Ru-Huei Fu, Hui-Jye Chen, Syuan-Yu Hong

Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson's Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway

水仙苷通过增强 MiR200a/Nrf-2/GSH 轴和介导 MAPK/Akt 相关信号通路对 6-OHDA 暴露的帕金森病模型发挥神经保护作用

期刊:Antioxidants

影响因子:

doi:10.3390/antiox11112089

Ru-Huei Fu, Chia-Wen Tsai, Shih-Ping Liu, Shao-Chih Chiu, Yen-Chuan Chen, Yu-Ting Chiang, Yun-Hua Kuo, Woei-Cherng Shyu, Shinn-Zong Lin

Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro

贝母碱通过调节 PINK1/Parkin 通路减少 ARTS 介导的 XIAP 降解，从而减轻体内和体外帕金森病模型中的 6-羟基多巴胺毒性和 α-突触核蛋白积累

期刊:International Journal of Molecular Sciences

影响因子:0.7

doi:10.3390/ijms221910240

Yu-Ling Hsu, Huey-Shan Hung, Chia-Wen Tsai, Shih-Ping Liu, Yu-Ting Chiang, Yun-Hua Kuo, Woei-Cherng Shyu, Shinn-Zong Lin, Ru-Huei Fu

Adipose-derived Stem Cells Stimulated with n-Butylidenephthalide Exhibit Therapeutic Effects in a Mouse Model of Parkinson's Disease

用正丁基苯酞刺激的脂肪干细胞在帕金森病小鼠模型中表现出治疗效果

期刊:Cell Transplantation

影响因子:3.2

doi:10.1177/0963689718757408

Kang Chi, Ru-Huei Fu, Yu-Chuen Huang, Shih-Yin Chen, Ching-Ju Hsu, Shinn-Zong Lin, Chi-Tang Tu, Li-Hsun Chang, Ping-An Wu, Shih-Ping Liu

Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation

缺血性中风患者血浆 L5 水平升高，并增强血小板聚集

期刊:Blood

影响因子:21

doi:10.1182/blood-2015-05-646117

Ming-Yi Shen, Fang-Yu Chen, Jing-Fang Hsu, Ru-Huei Fu, Chia-Ming Chang, Chiz-Tzung Chang, Chung-Hsiang Liu, Jia-Rong Wu, An-Sheng Lee, Hua-Chen Chan, Joen-Rong Sheu, Shinn-Zong Lin, Woei-Cherng Shyu, Tatsuya Sawamura, Kuan-Cheng Chang, Chung Y Hsu, Chu-Huang Chen

Irisflorentin improves α-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson's disease therapy

Irisflorentin 可改善 α-突触核蛋白的积累并减弱 6-OHDA 诱导的多巴胺能神经元变性，对帕金森病治疗有重要意义

期刊:BioMedicine-Taiwan

影响因子:

doi:10.7603/s40681-015-0004-y

Yue-Mi Chen, Shih-Ping Liu, Hsin-Lien Lin, Ming-Chia Chan, Yen-Chuan Chen, Yu-Ling Huang, Min-Chen Tsai, Ru-Huei Fu

Neural stem cells derived from α-synuclein-knockdown iPS cells alleviate Parkinson's disease

来自 α-突触核蛋白敲低 iPS 细胞的神经干细胞可缓解帕金森病

Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson's Disease

Chiisanoside 通过下调 MiR-181a 介导 Parkin/ZNF746/PGC-1α 轴，从而改善 6-OHDA 引起的神经毒性模型中的线粒体生物合成（体外和体内）：预防帕金森病的建议

Glycine-Alanine Dipeptide Repeat Protein from C9-ALS Interacts with Sulfide Quinone Oxidoreductase (SQOR) to Induce the Activity of the NLRP3 Inflammasome in HMC3 Microglia: Irisflorentin Reverses This Interaction

C9-ALS 中的甘氨酸-丙氨酸二肽重复蛋白与硫化物醌氧化还原酶 (SQOR) 相互作用，诱导 HMC3 小胶质细胞中 NLRP3 炎症小体的活性：Irisflorentin 可逆转这种相互作用

Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson's Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway

水仙苷通过增强 MiR200a/Nrf-2/GSH 轴和介导 MAPK/Akt 相关信号通路对 6-OHDA 暴露的帕金森病模型发挥神经保护作用

Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro

贝母碱通过调节 PINK1/Parkin 通路减少 ARTS 介导的 XIAP 降解，从而减轻体内和体外帕金森病模型中的 6-羟基多巴胺毒性和 α-突触核蛋白积累

Adipose-derived Stem Cells Stimulated with n-Butylidenephthalide Exhibit Therapeutic Effects in a Mouse Model of Parkinson's Disease

用正丁基苯酞刺激的脂肪干细胞在帕金森病小鼠模型中表现出治疗效果

Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation

缺血性中风患者血浆 L5 水平升高，并增强血小板聚集

Irisflorentin improves α-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson's disease therapy

Irisflorentin 可改善 α-突触核蛋白的积累并减弱 6-OHDA 诱导的多巴胺能神经元变性，对帕金森病治疗有重要意义